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to characterize the EVs of AD patients as a biomar-
ker for disease progression.
Methods: Blood samples were collected after
obtaining signed informed consent (No. 0462-14-
RMB) from 39 AD patients at three stages of disease
severity and from 14 healthy controls (HC).
Cerebrospinal fluid was collected from five patients
and three HC. EV size and concentration were
studied by Nano-tracking analysis. Membrane anti-
gens were characterized by their cell origin as
defined by flow cytometry. EV protein contents
were screened by protein array, and miRNA content
was screened by Nano-string technology and vali-
dated by RT-PCR.
Results: The AD patients’ EVs were significantly smal-
ler and the levels of neural cell markers were higher
than EVs obtained from HC. Moderate or severe AD
patients’ EVs had a significantly higher level of the
Myelin oligodendrocyte glycoprotein (MOG), com-
pared to the EVs obtained from patients with mild
AD (P = 0.0002 and P = 0.036). Levels of the EVs
that expressed the axonal glycoprotein CD171 were
significantly higher in the patients with severe AD
compared to HC (P = 0.0066), possibly indicating
injured apoptotic neural cells. There was also a signifi-
cant increase in EVs originating from endothelial cells
(labelled with CD31+ CD41-, P = 0.0115 and with
CD144, P = 0.0276) in patients with moderate AD
compared EVs obtained from the HC. A >2-fold
increase was measured in the content of inflammatory
cytokines (TNFα, IL8, IL-2, IFNγ) as was a >50%
reduction in growth factors (FGF, EGF VEGF) and
their receptors in the EVs of moderate AD patients.
miR-146a-5p and several other miRNAs obtained from
the EVs of severe AD patients had significantly low
levels compared to HC.
Summary/Conclusion: The neural and endothelial
damage severity as reflected by AD patients’ EVs (anti-
gen profiles cytokine and miRNA) may serve as a
biomarker for disease dynamics.
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Introduction: Biomarkers capable of identifying complex
pathways contributing to neuropathological development,
especially in the early stages of Alzheimer’s disease (AD),
are lacking. Such biomarkers could be present in easily
available fluids, such as blood, due to the breakdown of
the blood–brain barrier (BBB) early in AD. However, the
identification of specific and sensitive blood-based bio-
markers is a challenging task. Therefore, extracellular
vesicles (EVs) may provide a window into AD etiology
and therapeutic targets, as brain-derived EVs have been
shown to cross the BBB and are present in blood. As
biomarkers, proteins are a potential source of relevant
information relating to biological function. Thus, we
investigated a subset of proteins hypothesized to be
involved in neurological processes in plasma and EV
samples using the Proximity Extension Assay (PEA).
Methods: EVs were isolated from platelet poor plasma
from 10 healthy controls (HC), 10 patients with Mild
Cognitive Impairment (MCI) and 10 patients with
mild/moderate AD. Isolation was performed using cen-
trifugation at 20.000 xg, 1 h, 4°C with a subsequent
washing of the pellet at the same g-force. For the
characterization of the EV isolates, Nanosight and wes-
tern blotting (CD9) are performed. A neurology panel
of 92 biomarkers were assessed in plasma and EVs
using the PEA. Written informed consent was obtained
from all study participants and the study was approved
by The North Denmark Region Committee on Health
Research Ethics (N-20150010).
Results: PEA showed no significant difference of pro-
tein levels comparing the three groups for the plasma
samples. Interestingly, EV samples showed four statis-
tically significant proteins; Siglec-9, CLM-1, CLM-6
and CD38, which were less expressed in the MCI and
AD groups compared with the HC group with a false
discovery rate adjusted p-values of 0.014, 0.024, 0.035
and 0.031, respectively. These proteins have been docu-
mented to be involved in neurotoxicity protection and
inflammatory regulation.
Summary/Conclusion: Our preliminary results
demonstrate that EVs, compared to plasma, hold
potential as candidate diagnostic biomarkers in AD.
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Introduction: Astrocytes are abundant glial cells in the
central nervous system that provide supportive neuro-
nal functions. They have critical roles in regulating
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